Nasal Spray Recall: Health Risks and What You Need to Know
FDA Announces Recall of 89,312 Bottles of NasoGel
The U.S. Food and Drug Administration (FDA) has issued a recall of 89,312 bottles of NasoGel nasal spray. This action was taken due to potential “adverse” effects that may affect user health.
Manufacturer Issues Recall Due to Microbial Failure
NasoGel, manufactured by NeilMed Pharmaceuticals Inc., was the subject of this recall. NeilMed decided to take this step after receiving reports of an “unpleasant odor” from consumers, which could indicate microbial contamination.
Details of the Recall
The recall affects specific lots of NasoGel Spray, identified by lot numbers NGS751, NGS757, and NGS762. These products share a common UPC code of 00705928045309.
NeilMed received 11 reports from consumers noting the unusual odor, prompting a deeper investigation. Routine stability testing discovered potential microbial contamination, leading to this precautionary measure.
Where to Find the Recalled Product
The recalled spray was sold at various pharmacies and stores across the U.S., including Walgreens, Rite Aid, and Walmart. Consumers who purchased these products in the listed states should be cautious.
Recall Classification
The FDA classified this recall as a Class 2 device recall. This classification is used for products that may have potential to cause temporary or reversible health hazards if the issue is not corrected.
What Consumers Should Do
Consumers with the affected product are advised to contact NeilMed at questions@neilmed.com. When reaching out, they should include “NGS-PA” in the subject line to receive proper disposal instructions.
Affected States and International Recall
This recall encompasses numerous states within the U.S. and extends to several countries outside, including Bahrain, Ireland, Malaysia, Mexico, and the United Kingdom.
- Alabama
- Arizona
- California
- Colorado
- Connecticut
- Florida
- Georgia
- Idaho
- Illinois
- Indiana
- Kentucky
- Massachusetts
- Maryland
- Michigan
- Minnesota
- Missouri
- North Carolina
- New Jersey
- New Mexico
- New York
- Ohio
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- Tennessee
- Texas
- Virginia
- Vermont
- Washington
- Wisconsin
Ensuring Safety and Trust
This recall underscores the importance of stringent quality control in pharmaceutical manufacturing. NeilMed’s prompt action in addressing potential microbial issues demonstrates a commitment to consumer safety and trust.
Conclusion
Consumers should remain vigilant and check if they have purchased any of the affected NasoGel Spray lots. By following the FDA and NeilMed’s instructions, individuals can ensure their health and safety are not compromised by this recall.
Stay Informed
For any further updates on recalls or health advisories, stay tuned to our news portal. We are dedicated to providing you with accurate and timely information to keep you safe.
We encourage your thoughts and questions. Please feel free to comment below, subscribe to our newsletters for regular updates, and share this article on your social media platforms to help others stay informed.
